Defeat Duchenne Canada launches 2023 Research Grant Program
Defeat Duchenne Canada (DDC) is the country’s largest charitable source of investment in cutting-edge Duchenne muscular dystrophy research. DDC have funded $16 million into the most promising international research focussed on improving outcomes for all individuals with this progressive disease.
DDC invites all investigators working on translational or clinical Duchenne research to apply to their 2023 Research Grant Program!
Funding Criteria
Read the full funding criteria to learn more about the grant program.
Upcoming Deadlines
The deadline to submit a letter of intent is April 21st, 2023.
Submit a letter of intent through the DDC web portal.
Read next...
Important Deadlines for Ottawa NMD 2023
The Ottawa International Conference on Neuromuscular Disease and Biology (Ottawa NMD 2023) deadline for discounted early-bird registration and abstract submission is June 30th!
European Neuromuscular Centre Mid-Career Mentoring Programme Now Open
The European Neuromuscular Centre (ENMC) Mid-Career Mentoring Programme is now open for the third round of mentee candidates!
$6 million Brain Canada grant awarded to McGill to develop virtual integrated patient platform
NMD4C are pleased to share that The Neuro has received a $6 million grant from Brain Canada to fund a new Open Science patient registry to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.
CIHR Report: What we heard on the future of clinical trials
The Canadian Institute of Health Research (CIHR) have recently released an article outlining the results of their building the future of clinical trials consultation in a What We Heard report.
New Publication from NMD4C Investigators: Variability in Newborn Screening Across Canada: Spinal Muscular Atrophy and Beyond
A new study ‘Variability in Newborn Screening Across Canada: Spinal Muscular Atrophy and Beyond’ examines the differences between provincial newborn screening (NBS) programs and the variability of Spinal muscular atrophy (SMA) screening inclusion within these.
Muscular Dystrophy Canada fund nine new projects through 2023 grant program
Muscular Dystrophy Canada (MDC) recently announced the results of their ‘Neuromuscular Clinical and Translational Research Grant Program’, and we are pleased to celebrate the many NMD4C investigators and members who are leading and supporting projects!